-
Although the addition of PCI to optimal medical therapy in patients with chronic stable CHD reduced the prevalence of angina, it did not reduce the long-term rates of death, nonfatal myocardial infarctions and hospitalizations for acute coronary syndromes.
-
The FDA has approved the first of a new class of antibiotics for the topical treatment of impetigo. Retapamulin belongs to a class of agents called pleuromutilins.
-
Unless prophylaxed, most post-stroke patients with hemiplegia develop deep venous thrombosis (DVT), and as many as 20% sustain pulmonary embolism (PE).
-
A randomized controlled trial of 281 men with BPH showed that once daily Tadalafil (Cialis) 20 mg improved lower urinary tract symptoms compared with placebo.
-
A prediction tool that factors age, history of smoking, BMI, and alcohol use can determine a man's risk for colorectal cancer.
-
The new guidelines recommend antibiotic prophylaxis of infective endocarditis in a much more restricted group of patients than did previous guidelines.
-
Higher incidence of benign leukopenia from lower neutrophil counts is found in black persons compared to white in the United States, and Mexican-Americans and smokers have slightly higher routine counts.
-
Standard 10 day triple therapy for Helicobacter pylori may result in relatively low eradication rates. An alternative regimen of PPI plus amoxicillin for 5 days followed by PPI plus clarithromycin plus tinidazole for five days seems to provide significantly better H. pylori eradication.
-
The FDA has approved a transdermal patch for the treatment of early Parkinson's disease. Rotigotine is a non-ergoline, D3/D2/D1 dopamine receptor agonist. It is marketed by Schwarz Bioscience as Neupro.
-
The lead II rhythm strip image in this article was obtained from a middle-aged man in cardiac arrest. The patient had multiple co-morbidities ...
